The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain drugs can be selected for negotiation.
The post Trump’s Executive Order on Prescription Drug Costs Delivers a Win for Pharma Companies appeared first on MedCity News.
